Daiichi Sankyo’s full-year report was originally scheduled for April 27 but has now been pushed back to May 11. That same day ...

Daiichi Sankyo shares tumbled sharply on Friday after the Japanese pharmaceutical company announced a delay in its annual ...

Shares of Daiichi Sankyo tumbled after the Japanese drugmaker delayed the release of its earnings results. Daiichi Sankyo's stock declined nearly 11% to 2,497.50 yen, equivalent to $15.64, in Friday ...

Suntory Holdings Ltd. will buy Daiichi Sankyo Healthcare, the over-the-counter pharmaceuticals subsidiary of Daiichi Sankyo ...

Apart from Daiichi, a growing number of drugmakers have elected to part ways with their over-the-counter businesses in recent ...

The BLA submission for ifinatamab deruxtecan draws on data from the IDeate-Lung01 Phase II trial. Credit: 89stocker / ...

If you are wondering whether Daiichi Sankyo Company is starting to look like a bargain or still has room to fall, you are not alone; this stock has quietly shifted from market favorite to value ...

Hiroyuki Okuzawa will step into the role starting in April. Daiichi Sankyo announced that Hiroyuki Okuzawa will serve as its new CEO starting on April 1, 2025. 1 The previous CEO, Sunao Manabe, DVM, ...

Daiichi Sankyo is in talks with several companies over a sale of its over-the-counter (OTC) business, according to press reports. Citing Nikkei Business, Reuters reported that the final price is ...

Fatima Attarwala is a business news writer and editor with a decade of experience researching, analyzing, and commenting on issues influencing the economy. Bloomberg / Contributor / Getty Images Merck ...

TOKYO -- Japan's Suntory Holdings, a beverage giant that also sells health products, is to acquire drugmaker Daiichi Sankyo's ...